{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:24:50Z","timestamp":1770481490666,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.vaccine.2008.12.052","type":"journal-article","created":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T19:26:10Z","timestamp":1232565970000},"page":"1579-1584","source":"Crossref","is-referenced-by-count":46,"title":["Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease"],"prefix":"10.1016","volume":"27","author":[{"given":"Susanne","family":"Jacobsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara Thulin","family":"Hedberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"M\u00f6lling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Unemo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Comanducci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rino","family":"Rappuoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Olc\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9580","key":"10.1016\/j.vaccine.2008.12.052_bib1","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/S0140-6736(07)61016-2","article-title":"Epidemic meningitis, meningococcaemia, and Neisseria meningitidis","volume":"369","author":"Stephens","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2008.12.052_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4161\/hv.3.4.4174","article-title":"Meningococcal vaccines: to eradicate the disease, not the bacterium","volume":"3","author":"Taha","year":"2007","journal-title":"Hum Vacc"},{"issue":"5","key":"10.1016\/j.vaccine.2008.12.052_bib3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/infdis\/126.5.514","article-title":"Immunologic response of man to group B meningococcal polysaccharide vaccines","volume":"126","author":"Wyle","year":"1972","journal-title":"J Infect Dis"},{"issue":"8346","key":"10.1016\/j.vaccine.2008.12.052_bib4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"2","author":"Finne","year":"1983","journal-title":"Lancet"},{"issue":"29","key":"10.1016\/j.vaccine.2008.12.052_bib5","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.vaccine.2008.12.052_bib6","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infect Immun"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2008.12.052_bib7","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.vaccine.2005.01.055","article-title":"The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles","volume":"23","author":"Gorringe","year":"2005","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.vaccine.2008.12.052_bib8","doi-asserted-by":"crossref","first-page":"8420","DOI":"10.1016\/j.vaccine.2007.09.053","article-title":"Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate","volume":"25","author":"Delgado","year":"2007","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2008.12.052_bib9","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1128\/IAI.72.11.6511-6518.2004","article-title":"Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potential","volume":"72","author":"O\u2019Dwyer","year":"2004","journal-title":"Infect Immun"},{"issue":"17","key":"10.1016\/j.vaccine.2008.12.052_bib10","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1016\/j.vaccine.2006.02.003","article-title":"Vaccine potential of the Neisseria meningitidis lactoferrin-binding proteins LbpA and LbpB","volume":"24","author":"Pettersson","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2008.12.052_bib11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1369-5274(00)00119-3","article-title":"Reverse vaccinology","volume":"3","author":"Rappuoli","year":"2000","journal-title":"Curr Opin Microbiol"},{"issue":"5459","key":"10.1016\/j.vaccine.2008.12.052_bib12","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2008.12.052_bib13","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.vaccine.2005.01.063","article-title":"MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain","volume":"23","author":"Oster","year":"2005","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2008.12.052_bib14","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1084\/jem.20020407","article-title":"NadA, a novel vaccine candidate of Neisseria meningitidis","volume":"195","author":"Comanducci","year":"2002","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2008.12.052_bib15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2958.2004.04423.x","article-title":"Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells","volume":"55","author":"Capecchi","year":"2005","journal-title":"Mol Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.12.052_bib16","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1189\/jlb.1207810","article-title":"Human monocytes\/macrophages are a target of Neisseria meningitidis Adhesin A (NadA)","volume":"83","author":"Franzoso","year":"2008","journal-title":"J Leukocyte Biol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.12.052_bib17","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1128\/IAI.72.7.4217-4223.2004","article-title":"NadA diversity and carriage in Neisseria meningitidis","volume":"72","author":"Comanducci","year":"2004","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2008.12.052_bib18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","article-title":"The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance","volume":"177","author":"Madico","year":"2006","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.12.052_bib19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.vaccine.2008.12.052_bib20","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1086\/379375","article-title":"Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity","volume":"188","author":"Welsch","year":"2003","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2008.12.052_bib21","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.vaccine.2005.11.006","article-title":"Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens","volume":"24","author":"Jacobsson","year":"2006","journal-title":"Vaccine"},{"issue":"5459","key":"10.1016\/j.vaccine.2008.12.052_bib22","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1126\/science.287.5459.1809","article-title":"Complete genome sequence of Neisseria meningitidis serogroup B strain MC58","volume":"287","author":"Tettelin","year":"2000","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2008.12.052_bib23","first-page":"406","article-title":"The neighbor-joining method: a new method for reconstructing phylogenetic trees","volume":"4","author":"Saitou","year":"1987","journal-title":"Mol Biol Evol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.12.052_bib24","first-page":"569","article-title":"TREECON for Windows: a software package for the construction and drawing of evolutionary trees for the Microsoft Windows environment","volume":"10","author":"van de Peer","year":"1994","journal-title":"Comput Appl Biosci"},{"issue":"5","key":"10.1016\/j.vaccine.2008.12.052_bib25","first-page":"418","article-title":"Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions","volume":"3","author":"Nei","year":"1986","journal-title":"Mol Biol Evol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.12.052_bib26","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/bioinformatics\/17.12.1244","article-title":"MEGA2: molecular evolutionary genetics analysis software","volume":"17","author":"Kumar","year":"2001","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.vaccine.2008.12.052_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1574-6976.2006.00056.x","article-title":"Multilocus sequence typing for global surveillance of meningococcal disease","volume":"31","author":"Brehony","year":"2007","journal-title":"FEMS Microbiol Rev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09000103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09000103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T11:29:55Z","timestamp":1545478195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09000103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0264410X09000103"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.12.052","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}